TickerFactsScreenerDevelopers

NewAmsterdam Pharma Co N.V. (NAMS) — Operating Income

Annual figures by fiscal year, from SEC filings.

2021: -$34.98M2022: -$3.56M2023: -$182.97M2024: -$176.29M2025: -$225.68M-$225.68M
2021Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$225.68M-28.0%
2024-$176.29M+3.6%
2023-$182.97M-5043.9%
2022-$3.56M+89.8%
2021-$34.98M—